3 results match your criteria: "4-584 Edmonton Clinic Health Academy[Affiliation]"
Sickle cell bone disease and response to intravenous bisphosphonates in children.
Osteoporos Int
November 2022
Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada.
Unlabelled: Children with sickle cell disease (SCD) have the potential for extensive and early-onset bone morbidity. This study reports on the diversity of bone morbidity seen in children with SCD followed at three tertiary centers. IV bisphosphonates were effective for bone pain analgesia and did not trigger sickle cell complications.
View Article and Find Full Text PDFN-of-1 Trials, Their Reporting Guidelines, and the Advancement of Open Science Principles.
Harv Data Sci Rev
September 2022
Dept of Pediatrics and Psychiatry, Faculty of Medicine & Dentistry, University of Alberta, 4-584 Edmonton Clinic Health Academy, 11405-87 Ave NW, Edmonton, AB, T6G 1C9. Canada.
Article Synopsis
- * Best practices like the SPENT and CENT guidelines promote transparent reporting and contribute to the goals of open science, which aims to enhance research collaboration and accessibility.
- * While N-of-1 trials foster patient-centered research and greater equity, they also highlight concerns about post hoc analysis monitoring and confidentiality, particularly for sensitive data in rare diseases.
Study of Natural Products Adverse Reactions (SONAR) in Adults with Mental Health Conditions: A Cross-Sectional Study.
Drug Saf
September 2021
Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, 4-584 Edmonton Clinic Health Academy (ECHA), 11405-87 Ave NW, Edmonton, AB, T6G 1C9, Canada.
Article Synopsis
- Mental illness significantly contributes to non-fatal disease worldwide, leading patients to seek natural health products (NHPs) as safer alternatives to conventional medications, despite unknown risks of adverse events (AEs) and interactions with prescribed drugs.
- The study aimed to assess the prevalence of adult mental health patients using only prescription meds, only NHPs, both, or neither, and to identify common products and AEs experienced in the past month.
- Results showed that among 3079 patients, those using both NHPs and prescriptions reported the highest AEs (58.8%), suggesting that combining these increases the risk of experiencing adverse effects compared to those using only one type of treatment.